NCT04767984View on ClinicalTrials.gov

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 24, 2021

Primary Completion Date

January 30, 2026

Study Completion Date

November 30, 2026

Conditions
Colorectal CarcinomaUlcerative Colitis
Interventions
DRUG

Atorvastatin Calcium

Given PO

PROCEDURE

Biopsy of Colon

Undergo colonoscopy with biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

DRUG

Placebo Administration

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (3)

60611

Northwestern University, Chicago

60637

University of Chicago Comprehensive Cancer Center, Chicago

66160

University of Kansas Cancer Center, Kansas City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER